×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Neuphoria Therapeutics Financial Ratios for Analysis 2021-2025 | NEUP
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Income Statement
Balance Sheet
Cash Flow Statement
Key Financial Ratios
Format: Annual
Format: Quarterly
Format: Annual
View Annual Reports
Loading...
Annual Data
2024-06-30
2023-06-30
2022-06-30
2021-06-30
Current Ratio
3.4457
4.8659
12.4597
13.1016
Long-term Debt / Capital
-
-
0.0093
0.0144
Debt/Equity Ratio
-
-
0.0122
0.0182
Gross Margin
-
-
100
-
Operating Margin
-
-
-8309.628
-
EBIT Margin
-
-
-8309.628
-
EBITDA Margin
-
-
-7888.813
-
Pre-Tax Profit Margin
-
-
-8326.379
-
Net Profit Margin
-
-
-8253.624
-
Asset Turnover
-
-
0.004
-
Inventory Turnover Ratio
-
-
-
-
Receiveable Turnover
-
-
0.0389
-
Days Sales In Receivables
-
-
9392.583
-
ROE - Return On Equity
-88.5754
-97.1429
-38.2328
-18.272
Return On Tangible Equity
-464.8348
-297.5412
-63.6118
-34.4423
ROA - Return On Assets
-56.0314
-74.8581
-33.317
-16.0274
ROI - Return On Investment
-88.5754
-97.1428
-37.8777
-18.0096
Book Value Per Share
15.8503
32.3814
65.9239
76.2682
Operating Cash Flow Per Share
3.8878
3.6653
-9.5937
-15.6063
Free Cash Flow Per Share
3.8878
3.4643
-9.4634
-15.5356
www.jqwidgets.com
